Hu, Chengyu
Liu, Hongming
Hong, Bo
Wang, Li
Wu, Zelai
Xie, Weixun
Luo, Bixian
Cao, Dong
Zhong, Yuxin
Liu, Yong
Gong, Weihua
Funding for this research was provided by:
Key Research and Development Program of Zhejiang Province (No. 2025C02054)
Article History
Received: 20 November 2024
Accepted: 1 April 2025
First Online: 23 April 2025
Declarations
:
: The study protocol was approved by the ethical committees of the Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine. (NO.20241049) National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (August 27, 2024) and Tianjin Medical University Cancer Institute & Hospital (June 26, 2024). Informed consent was obtained from all the subjects. As it was a retrospective follow-up study verbal consent was obtained from all patients as well as approval from the ethics committee.
: Not applicable.
: The authors declare no competing interests.